# Anthropic acquires Mithril Medicine as it expands drug discovery work

_Published Wednesday, November 11, 2026 at 11:18 PM EST · AI · Latest · Tier 2 — Notable_

![Anthropic acquires Mithril Medicine as it expands drug discovery work — Primary](https://img.etimg.com/thumb/msid-135744883,width-1200,height-900,imgsize-51508,overlay-economictimes/articleshow.jpg)

Anthropic has acquired Mithril Medicine, a one-person drug developer focused on muscular dystrophy, The Economic Times reported. Founder Cody Tranbarger used Claude to coordinate contracts, experiments and work by 11 external laboratories. The company claims one potential drug progressed from conception to mouse trials in less than 18 months.

Anthropic has also launched its own drug discovery programs and is collaborating with companies including Generate Biomedicines and BigHat Biosciences. Most of the science remains preclinical. Anthropic anticipates a drug could be ready for human trials in late 2028 if further studies produce promising results.

## Sources

- [The Economic Times](https://economictimes.indiatimes.com/news/science/dario-amodei-says-ai-could-make-cancer-alzheimers-relics-of-the-past-in-less-than-a-decade-as-anthropic-expands-ai-driven-drug-discovery-push/articleshow/135744334.cms)

---
Canonical: https://techandbusiness.org/newswire/d-27sgi8SUfTv1bOzPhLjO
Published: 2026-11-12T04:18:36.258Z
Story chronology: 2026-11-11T17:11:00.000Z
Retrieved: 2026-11-12T06:58:39.023Z
Publisher: Tech & Business (techandbusiness.org)